The global Intravenous Immunoglobulin market size in 2023 is 14783.8 million US dollars, and it is expected to be 25320.5 million US dollars by 2030, with a compound annual growth rate of 8.0% expected in 2024-2030.
MARKET COMPETITIVE LANDSCAPE:
The main players in the Intravenous Immunoglobulin market include Biotest AG, Octapharma AG, LFB Biotechnologies, Grifols SA, and CSL Behring. The share of the top 3 players in the Intravenous Immunoglobulin market is XX%.
REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Intravenous Immunoglobulin market, and Asia Pacific accounted for XX%.
SEGMENT OVERVIEW:
The report segments the market by Type and Application. IGG accounted for XX% of Intravenous Immunoglobulin market in 2023. IGA share of XX%.
Hypogammaglobulinemia accounted for XX% of the Intravenous Immunoglobulin market in 2023. Chronic Inflammatory demyelinating polyneuropathy (CIDP) accounts for XX%.
The report includes the analysis of impact of COVID-19 lock-down on the revenue of market leaders, followers, and disrupters. Since lock down was implemented differently in different regions and countries, impact of same is also different by regions and segments. The report has covered the current short term and long term impact on the market, same will help decision makers to prepare the outline for short term and long term strategies for companies by region.
The objective of the report is to present a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, industry-validated market data and projections with a suitable set of assumptions and methodology. The report also helps in understanding Global Intravenous Immunoglobulin Market dynamics, structure by identifying and analyzing the market segments and project the global market size.
In addition, the market SWOT analysis, dynamics, trends, technologies, opportunities and challenges analysis are covered in the report.
Further, the report also focuses on the competitive analysis of key players by product, financial position, product portfolio, growth strategies, and regional presence.
Chapter Outline
Chapter 1: Introduces the product overview, market scope, product classification, application, and regional division, and then includes inflation analysis, the impact of the Russo-Ukrainian war on the market, and the global impact of the coronavirus disease (COVID-19).
Chapter 2: Analysis of the competitive environment of Intravenous Immunoglobulin market participants. This mainly includes the revenue and market share of the top players, along with the players” M&A and expansion in recent years.
Chapter 3: Analyzes the main companies in the Intravenous Immunoglobulin industry, including their main businesses, products/services, revenue, gross margin, and the latest developments.
Chapters 4-6: Segmented the global Intravenous Immunoglobulin market by type, application and region. Analyze the revenue of market segments from different perspectives.
Chapters 7-10: Provide Americas, Europe, Asia-Pacific and Middle East & Africa Intravenous Immunoglobulin market country segmentation data.
Chapter 11: Introduces the market dynamics, the trends factors and drivers factors of the market, and the challenges and restraints faced by manufacturers in the industry.
Chapters 12-14: Provide detailed Intravenous Immunoglobulin market forecast data, broken down by type, application, and region to help understand future growth trends.
Chapter 15: The main points and conclusions of the report.
Chapter 16: Concludes with an explanation of the data sources and research methods.
Highlights-Regions
Americas
United States
Canada
Brazil
Argentina
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
MEA
Saudi Arabia
UAE
Turkey
Player list
Biotest AG
Octapharma AG
LFB Biotechnologies
Grifols SA
CSL Behring
China Biologics Products Inc.
Kedrion Biopharma
BDI Pharma Inc.
Types list
IGG
IGA
IGM
IGE
IGD
Application list
Hypogammaglobulinemia
Chronic Inflammatory demyelinating polyneuropathy (CIDP)
Immunodeficiency diseases
Myasthenia Gravis
Multifocal motor neuropathy
Idiopathic thrombocytopenic purpura (ITP)
Inflammatory myopathies
Specific antibody deficiency
Guillain-Barre syndrome
List of Tables and Figures
Figure Intravenous Immunoglobulin Picture
Table Product Definition of Intravenous Immunoglobulin
Table Global Intravenous Immunoglobulin Market Size Growth Rate by Type, 2019 VS 2024 VS 2030
Table Global Intravenous Immunoglobulin Market Size Growth Rate by Application, 2019 VS 2024 VS 2030
Table Global Intravenous Immunoglobulin Market by Region: 2019 VS 2024 VS 2030
Figure Global Intravenous Immunoglobulin Revenue Market Size & Forecasts 2019-2030
Figure Years Considered
Table Inflation Analysis
Table The Impact of the Russian-Ukrainian War on the Market
Figure (COVID-19) Impact on Global Economic Growth 2019, 2020, 2021
Figure Population infected by the Covid-19 of Major Countries
Table Global Intravenous Immunoglobulin Revenue by Players (2019-2024)
Table Global Intravenous Immunoglobulin Revenue Market Share by Players (2019-2024)
Figure Top 5 Largest Players of Intravenous Immunoglobulin in 2024
Figure Top 10 Largest Players of Intravenous Immunoglobulin in 2024
Table Global Intravenous Immunoglobulin Gross Margin by Players
Table Players Market Concentration Ratio (CR5)
Table Global Intravenous Immunoglobulin Players Geographical Distribution
Table Mergers & Acquisitions, Expansion Plans
Table Company Profiles
Table Biotest AG Overview
Table Biotest AG Revenue, Gross, Gross Margin 2019-2024
Table Biotest AG Related Developments
Table Company Profiles
Table Octapharma AG Overview
Table Octapharma AG Revenue, Gross, Gross Margin 2019-2024
Table Octapharma AG Related Developments
Table Company Profiles
Table LFB Biotechnologies Overview
Table LFB Biotechnologies Revenue, Gross, Gross Margin 2019-2024
Table LFB Biotechnologies Related Developments
Table Company Profiles
Table Grifols SA Overview
Table Grifols SA Revenue, Gross, Gross Margin 2019-2024
Table Grifols SA Related Developments
Table Company Profiles
Table CSL Behring Overview
Table CSL Behring Revenue, Gross, Gross Margin 2019-2024
Table CSL Behring Related Developments
Table Company Profiles
Table China Biologics Products Inc. Overview
Table China Biologics Products Inc. Revenue, Gross, Gross Margin 2019-2024
Table China Biologics Products Inc. Related Developments
Table Company Profiles
Table Kedrion Biopharma Overview
Table Kedrion Biopharma Revenue, Gross, Gross Margin 2019-2024
Table Kedrion Biopharma Related Developments
Table Company Profiles
Table BDI Pharma Inc. Overview
Table BDI Pharma Inc. Revenue, Gross, Gross Margin 2019-2024
Table BDI Pharma Inc. Related Developments
Table Global Intravenous Immunoglobulin Revenue by Type (2019-2024)
Table Global Intravenous Immunoglobulin Revenue Share by Type (2019-2024)
Table Global Intravenous Immunoglobulin Revenue by Application (2019-2024)
Table Global Intravenous Immunoglobulin Revenue Share by Application (2019-2024)
Figure Global Intravenous Immunoglobulin Market Revenue 2019-2024
Table Global Intravenous Immunoglobulin Revenue by Region (2019-2024)
Table Global Intravenous Immunoglobulin Revenue Share by Region (2019-2024)
Figure Americas Intravenous Immunoglobulin Revenue (2019-2024)
Figure Europe Intravenous Immunoglobulin Revenue (2019-2024)
Figure Asia-Pacific Intravenous Immunoglobulin Revenue (2019-2024)
Figure Middle East & Africa Intravenous Immunoglobulin Revenue (2019-2024)
Table Americas Intravenous Immunoglobulin Revenue by Country (2019-2024)
Table Americas Intravenous Immunoglobulin Revenue Share by Country (2019-2024)
Figure United States Intravenous Immunoglobulin Revenue Market Size (2019-2024)
Figure Canada Intravenous Immunoglobulin Revenue Market Size (2019-2024)
Figure Mexico Intravenous Immunoglobulin Revenue Market Size (2019-2024)
Figure Brazil Intravenous Immunoglobulin Revenue Market Size (2019-2024)
Figure Argentina Intravenous Immunoglobulin Revenue Market Size (2019-2024)
Table Europe Intravenous Immunoglobulin Revenue by Country (2019-2024)
Table Europe Intravenous Immunoglobulin Revenue Share by Country (2019-2024)
Figure Germany Intravenous Immunoglobulin Revenue Market Size (2019-2024)
Figure France Intravenous Immunoglobulin Revenue Market Size (2019-2024)
Figure U.K. Intravenous Immunoglobulin Revenue Market Size (2019-2024)
Figure Italy Intravenous Immunoglobulin Revenue Market Size (2019-2024)
Figure Russia Intravenous Immunoglobulin Revenue Market Size (2019-2024)
Table Asia Pacific Intravenous Immunoglobulin Revenue by Region (2019-2024)
Table Asia Pacific Intravenous Immunoglobulin Revenue Share by Region (2019-2024)
Figure China Intravenous Immunoglobulin Revenue Market Size (2019-2024)
Figure Japan Intravenous Immunoglobulin Revenue Market Size (2019-2024)
Figure South Korea Intravenous Immunoglobulin Revenue Market Size (2019-2024)
Figure India Intravenous Immunoglobulin Revenue Market Size (2019-2024)
Figure Southeast Asia Intravenous Immunoglobulin Revenue Market Size (2019-2024)
Figure Australia Intravenous Immunoglobulin Revenue Market Size (2019-2024)
Table Middle East and Africa Intravenous Immunoglobulin Revenue by Country (2019-2024)
Table Middle East and Africa Intravenous Immunoglobulin Revenue Share by Country (2019-2024)
Figure Turkey Intravenous Immunoglobulin Revenue Market Size (2019-2024)
Figure Saudi Arabia Intravenous Immunoglobulin Revenue Market Size (2019-2024)
Figure U.A.E Intravenous Immunoglobulin Revenue Market Size (2019-2024)
Table Global Intravenous Immunoglobulin Forecasted Revenue by Type (2019-2024)
Table Global Intravenous Immunoglobulin Forecasted Revenue Share by Type (2019-2024)
Table Global Intravenous Immunoglobulin Forecasted Revenue by Application (2019-2024)
Table Global Intravenous Immunoglobulin Forecasted Revenue Share by Application (2019-2024)
Figure Global Intravenous Immunoglobulin Market Revenue Forecasts 2024-2030
Table Global Intravenous Immunoglobulin Forecasts Revenue by Region (2024-2030)
Table Global Intravenous Immunoglobulin Forecasts Revenue Share by Region (2024-2030)
Figure Americas Intravenous Immunoglobulin Forecasts Revenue and Growth (2024-2030)
Figure Europe Intravenous Immunoglobulin Forecasts Revenue and Growth (2024-2030)
Figure Asia-Pacific Intravenous Immunoglobulin Forecasts Revenue and Growth (2024-2030)
Figure Middle East & Africa Intravenous Immunoglobulin Forecasts Revenue and Growth (2024-2030)
Table Research Process
Figure Bottom-up and Top-down Approaches for This Report